Transaction · 0001610717-26-000422

Suliman Shehnaaz

SULIMAN SHEHNAAZ, DIR, reported an open-market or private sale at 10x Genomics, Inc. involving 614.000000 shares for an estimated $48820.00. Reported holdings after the transaction were 28609.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
TXG10x Genomics, Inc.
Trade date
Sep 22, 2026
Filing date
Sep 24, 2026
View on SEC Insider profile
Estimated value-$48.8kShares × reported price
Shares traded614$79.51 per share
Holdings after28.6kDirect
% of reported position traded2.1%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 29,223 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TXG price since this filing

Daily closing prices, with the filing date and available return windows
TXG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -22.6%1w ago -11.6%1d ago -6.0%
Returns since7d +5.5%30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000422
Class A Common Stock
Transaction date
Sep 22, 2026
Filed Sep 24, 2026, 08:30 PM · 2d delay
Shares
614 sh
$79.51 per share
Estimated value
-$48.8k
Computed from shares × price
Holdings after
28,609 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $77.76 to $78.74, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $79.075 to $80.07, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $80.08 to $81.0769, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertake…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $81.08 to $82.0791, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertake…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $82.08 to $82.56, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

Original filing · 0001610717-26-000422
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TXG